EXACT Sciences Operating Cycle Over Time
| EXAS Stock | USD 102.66 0.39 0.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out EXACT Sciences Performance and EXACT Sciences Correlation. Is there potential for Biotechnology market expansion? Will EXACT introduce new products? Factors like these will boost the valuation of EXACT Sciences. Projected growth potential of EXACT fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.38) | Revenue Per Share | Quarterly Revenue Growth 0.201 | Return On Assets | Return On Equity |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between EXACT Sciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EXACT Sciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, EXACT Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Cycle Analysis
Compare EXACT Sciences and related stocks such as Guardant Health, ICON PLC, and Viatris Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GH | 96.2065 | 96.2065 | 96.2065 | 96.2065 | 96.2065 | 96.2065 | 96.2065 | 178 | 221 | 160 | 157 | 186 | 199 | 157 | 144 | 130 | 133 |
| ICLR | 186 | 135 | 151 | 143 | 144 | 148 | 146 | 147 | 118 | 132 | 158 | 138 | 133 | 130 | 126 | 113 | 106 |
| VTRS | 252 | 228 | 227 | 251 | 231 | 240 | 228 | 204 | 225 | 225 | 393 | 205 | 225 | 236 | 242 | 278 | 269 |
| BBIO | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 25.6022 | 103 | 103 | 80.2833 | 68.6999 | 7.7671 | 8.93 | 8.49 |
| SMMT | 281 | 45.2821 | 47.8922 | 650 | 650 | 650 | 231 | 231 | 51.4081 | 3.2 K | 4.3 K | 4.9 K | 3.2 K | 3.2 K | 3.2 K | 3.6 K | 3.8 K |
| RVTY | 177 | 158 | 155 | 156 | 159 | 153 | 152 | 194 | 164 | 174 | 216 | 168 | 163 | 193 | 199 | 179 | 108 |
| ROIV | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 82.3891 | 212 | 44.4449 | 301 | 9 K | 9 K | 8.1 K | 8.5 K |
| RVMD | 132 | 132 | 132 | 132 | 132 | 132 | 132 | 132 | 132 | 63.7278 | 54.2876 | 73.6334 | 48.2093 | 39.5259 | 39.5259 | 45.45 | 75.46 |
| DOCS | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 65.1075 | 82.0457 | 88.7709 | 86.1354 | 93.2394 | 77.7965 | 82.1341 | 73.92 | 65.74 |
| QGEN | 340 | 200 | 204 | 190 | 185 | 203 | 190 | 214 | 215 | 235 | 262 | 225 | 247 | 295 | 186 | 208 | 266 |
EXACT Sciences and related stocks such as Guardant Health, ICON PLC, and Viatris Operating Cycle description
My Equities
My Current Equities and Potential Positions
| EXACT Sciences | EXAS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 5505 Endeavor Lane, |
| Exchange | NASDAQ Exchange |
USD 102.66
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.